Updated:
Hildred Partners
Howard Solomon and his son David Solomon co-founded Hildred Partners in 2014, channeling the wealth and operational playbook forged during the elder Solomon's...
Hildred Partners
Howard Solomon and his son David Solomon co-founded Hildred Partners in 2014, channeling the wealth and operational playbook forged during the elder Solomon's decades-long run as CEO of Forest Laboratories. Andrew Goldman, the firm's third founder, serves as Chief Investment Officer. The firm operates from a single office on Fifth Avenue in Midtown Manhattan, managing a healthcare-dedicated portfolio that the firm's website characterizes as deploying approximately $4 billion. Hildred pursues control and growth-equity investments exclusively in North American middle-market healthcare. It targets companies generating $10–$100 million in revenue, with transaction enterprise values between $50 million and $500 million. The firm's direct investment strategy spans pharma services, healthcare IT, and multisite provider roll-ups. Confirmed portfolio companies include Tebra, which received a $250 million equity-and-debt package from Hildred to accelerate AI and automation R&D, and the merged ambulatory infusion platform now called AleraCare. Hildred looks to drive returns through operational improvements — revenue growth, margin expansion, and strategic repositioning — rather than multiple expansion or aggressive leverage. In a notable structural move, the firm created a continuation vehicle in partnership with co-investor Lexington Partners to hold assets beyond a traditional fund term, a transaction pegged at $750 million (per Altss estimate). The firm participates in club and co-investment structures alongside other institutional investors. David Solomon's civic footprint is significant — he serves as President of the Board of Lincoln Center, while the late Howard Solomon was Chairman Emeritus of the New York City Ballet and an Executive Committee member of the Metropolitan Opera. Hildred operates as an independent private equity manager distinct from any single-family pool, though the Solomon family's wealth remains the anchor capital. The firm's governance separates the investment team, led by Goldman, from the family's broader philanthropic vehicles, such as the Triangle Fund. This architecture gives the firm a permanent-capital base while pursuing third-party institutional co-investors, creating a hybrid posture that blends family-office patience with institutional discipline.
General information
Firm type
Single Family Office
Location
Region
North America
Country
United States
City
New York
Corporate office
745 Fifth Avenue, Suite 800, New York, NY 10151, United States
Principals
Howard Solomon
Founder
David Solomon
Co-founder and Managing Partner
Andrew Goldman
Co-founder and Managing Partner; Chief Investment Officer
Stephen Hallenbeck
Partner
Sector focus
Frequently asked questions
Who makes the investment decisions at Hildred Partners?
Andrew Goldman is the firm's Chief Investment Officer and leads deal execution, drawing on the healthcare operating experience of founders Howard and David Solomon. The team deploys a committee-based process rooted in the operational playbook Howard Solomon developed as CEO of Forest Laboratories.
How does Hildred source its deals?
Hildred leans on the founders' decades-long healthcare networks rather than broad auction processes. The firm's materials emphasize proprietary sourcing through relationships built during Howard Solomon's career at Forest Laboratories and David Solomon's prominent New York civic board roles, including Lincoln Center.
Is Hildred a single-family office or a traditional private equity firm?
Hildred operates as an independent private equity manager. Although the Solomon family's capital anchors the firm, Hildred raises co-investment capital from institutional partners like Lexington Partners and pursues third-party commitments. It does not function as a consolidated single-family office.
Does Hildred participate in continuation vehicles or secondaries?
Yes. Hildred executed a $750 million continuation vehicle with Lexington Partners to extend its hold on certain portfolio assets beyond a traditional fund term (per Altss estimate). This structure is a key tool in its long-duration approach to healthcare investing.
What check size does Hildred typically write?
The firm targets companies with $10–$100 million in revenue, and transaction enterprise values typically range from $50 million to $500 million. Its equity checks are sized to achieve control or significant minority positions in lower-middle-market healthcare businesses.
How does Hildred's relationship with the Solomon family's philanthropy work?
Hildred's investment activities are separate from the Solomon family's philanthropic structures, such as the Triangle Fund. David Solomon's civic board work — notably as President of Lincoln Center — is conducted independently from the firm's investment operations.
Does Hildred avoid any specific healthcare sub-sectors?
Hildred's public materials emphasize middle-market services, technology, and provider platforms, and it has disclosed investments in specialties like infusion therapy and practice management software. It has not explicitly ruled out sub-sectors but its operational focus heavily favors cash-pay and provider-reimbursement models over early-stage biotech or pure pharmaceutical R&D.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: